Longevity Health Holdings, Inc.
XAGE
$2.41
-$0.06-2.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2,816.57% | -14.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2,816.57% | -14.63% | |||
| Cost of Revenue | 19,941.67% | -75.00% | |||
| Gross Profit | 1,555.21% | 3.82% | |||
| SG&A Expenses | 90.72% | -24.87% | |||
| Depreciation & Amortization | 30.43% | 2.22% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 96.91% | -28.88% | |||
| Operating Income | -49.65% | 29.08% | |||
| Income Before Tax | -48.86% | 64.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -64.71% | 68.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -64.71% | 68.24% | |||
| EBIT | -49.65% | 29.08% | |||
| EBITDA | -50.02% | 29.49% | |||
| EPS Basic | -15.78% | 68.23% | |||
| Normalized Basic EPS | -4.64% | 64.30% | |||
| EPS Diluted | -15.78% | 68.23% | |||
| Normalized Diluted EPS | -4.64% | 64.30% | |||
| Average Basic Shares Outstanding | 42.27% | -0.01% | |||
| Average Diluted Shares Outstanding | 42.27% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||